Log-in / Create Account  
ENDO 2011 Annual Meeting Session List
Click here to search this conference.
Display sessions grouped by:
Track Session Code Speaker Date

Track: 

Conference Set
Free Sessions
 CLINICAL
 TRANSLATIONAL
 BASIC
 

Conference Set

CON  ENDO 2011 Annual Meeting Full Conference Online Access 
Back to Top
Free Sessions

CP1  CLINICAL - Evaluation, Treatment & Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline   
CP2  CLINICAL - Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline   
CS1  The History of the Endocrinology of Vitamin D   
Back to Top
CLINICAL

CMF01  Inpatient Management of Blood Glucose Levels   
CMF02  Management of Apparent Secondary Hypogonadism due to Obesity, Opiates & Anabolic Steroids   
CMF03  Risk Assessment for Osteoporotic Fracture   
CMF04  Thyroid Nodules & Cancer in Children   
CMF05  Gauging Response to Osteoporosis Therapy   
CMF06  AACE vs ADA Guidelines for Diagnosis & Management of DM2   
CMF07  Diagnosis of Thyroid Cancer using Ultrasound & FNA   
CMF08  Investigation & Management of Gynecomastia   
CMF09  Endocrine Management of the Bariatric Patient   
CMF10  Management of Opiate-Induced Neuroendocrine Dysfunction   
CMF12  Primary Hyperaldosteronism   
CMF13  Management of Subclinical Hyperthyroidism   
CMF14  Medical Therapy of Cushing's Disease: Safety & Efficacy   
CMF15  Lipid Management Cases by the Guidelines or by Common Sense?   
CMF16  Non-Insulin Treatment of Diabetes Mellitus in Children & Adolescents   
M01  Delayed Puberty   
M02  Difficult Diabetes Cases   
M03  Drug Therapies for Osteoporosis: When, Which & How Long to Use?   
M04  Laboratory & Radiologic Evaluation of the Adrenal Incidentaloma   
M05  Management of Hypertriglyceridemia   
M06  Disorders of Sexual Development in Adults   
M07  Evaluation of the Transition Patient for GH Replacement   
M08  Investigating Mineralocorticoid Hypertension   
M09  Metabolic Management of PCOS   
M10  New Options in the Investigation & Management of (Neuro-) Endocrine Tumors of the Digestive Tract & Pancreas   
M11  Phosphate Disorders in Children & Adolescents   
M12  Surgical Management of Thyroid Cancer   
M13  When & How To Use Vitamin D   
M14  Amenorrhea   
M15  Interpretation of Challenging TFTs   
M16  Management of Hypogonadism through Puberty   
M17  Managing CV Risk in Type 2 Diabetes   
M18  Pheochromocytoma & Paraganglioma Syndromes: What's New?   
M20  Value of Medical Therapy before Pituitary Surgery   
M21  What to do for Sweating & Flushing   
M23  Controversies in Cushing's Syndrome   
M25  Insulin Pumps   
M26  Issues in the Diagnosis & Treatment of Klinefelter's Syndrome   
M27  Management Issues in Adult GH Replacement   
M28  Treatment of Severe Thyrotoxicosis   
M29  Cases from the Metabolic Bone Clinic   
M30  Diagnostic Strategy for Post-Menopausal Androgen Excess   
M31  Dopamine Agonists: When to Use, What to Choose & Safety Issues   
M32  Management of Hormone Replacement in Addison's Disease   
M33  Management of Hypogonadotropic Hypogonadism   
M34  Management of Idiopathic Short Stature   
M35  Controversies in the Diagnosis of Diabetes Mellitus   
M36  Diagnosis & Management of Male Hypogonadism in the Older Man   
M37  Investigation & Management of Hypocalcemia   
M38  Management of Gender Variant Youth   
M39  Pediatric Thyroid Nodules & Cancer   
M40  Clinical Management of Adrenocortical Carcinoma   
M41  Continuous Glucose Monitoring & its Role in Diabetes Management   
M42  Key Issues in Managing the Perimenopause   
M43  Klinefelter's Syndrome from Cradle through Adolescence   
M45  Renal Bone Disease for the Endocrinologist   
M46  Who Needs MODY Screening?   
M47  Erectile Dysfunction: Who, When, What Treatment?   
M48  Management of CAH in the Adult & Child   
M49  Management of Mild Primary Hyperparathyroidism   
M50  Management of Subtle & Overt Thyroid Dysfunction from Infancy Through Puberty   
M51  Pregnancy & Management of Diabetes: Before, During & After   
M53  An Endocrinologist's Use of Vasopressin Antagonists   
MC1  Difficult Thyroid Cancer Cases   
PMW1   Academic Practice Management Forum 2011 
PMW1-1  Obtaining Resources Required to Run An Academic Practice   
PMW1-2  How To Negotiate with Your Health System for an In-Patient Diabetes Program   
PMW1-3  Supporting the Professional Success of Faculty in an Academic Practice   
PMW1-4  Q and A   
S08  Aromatase Inhibitors in Pediatrics 
S08-1  Aromatase Inhibitors: The Good, Bad, & Unknown   
S08-2  Aromatase Inhibitors: Therapeutic Uses in Males   
S08-3  Aromatase Inhibitors in McCune Albright Syndrome   
S09  Autoimmune Thyroid Disease: What's New in Clinical Practice? 
S09-1  Controversies in the Management of Graves' Disease in Children   
S09-2  New Approaches to the Management of Graves' Eye Disease   
S09-3  "Elevated" TSH in the Elderly: Physiologic or Pathologic   
S10  Consequences of Androgen Excess in Women 
S10-1  Cardiovascular Dysfunction in PCOS   
S10-2  Hepatic Dysfunction in PCOS   
S10-3  Dyslipidemia in PCOS   
S18  Aldosterone Excess: Technology, Strategies & Outcomes 
S18-1  Adrenal Vein Sampling:State of the Art   
S18-2  Workup of Primary Aldosterononism: Punt or Go Long?   
S18-3  Benefits of Mineralocorticoid Antagonist Therapy   
S19  Genetics of Osteoporosis 
S19-1  Explorations in Animal Models   
S19-2  Candidate Genes in Human Osteoporosis   
S19-3  Applications for Clinical Management   
S20  The Difficulties of Weight Loss Maintenance 
S20-2  Fighting Weight Regain: The Role of Exercise   
S20-3  Strategies to Prevent Weight Regain: Lessons Learned from Successful Losers   
S29  Advances in the Management of Acromegaly 
S29-1  Reproductive Function and Pregnancy in Acromegaly   
S29-2  How Good Are Non-selective Somatostatin Analogues in Acromegaly?   
S30  Biological Mechanisms for Global Disparities in Type 2 Diabetes & Its Complications: Controversies & Advances 
S30-1  Flatbush Diabetes: Unique Pathophysiologic Features of Type 2 Diabetes in Patients of African or Southeastern Asian Descent   
S30-2  Disparities in Type 2 Diabetes Among Indigenous Populations around the World   
S30-3  Genetic & Ethnic Considerations in Type 2 Diabetes: Complications around the World: How Much Does Biology Matter?   
S31  Controversies in the Clinical Guidelines for Diagnosis & Management of Male Hypogonadism 
S31-1  Diagnosis of Male Hypogonadism   
S31-3  Adverse Effects of Testosterone Therapy   
S39  Endocrine Neoplasias from Top to Bottom 
S39-1  Mechanisms of Parathyroid Cancer from Inherited Syndromes   
S39-3  MIS as a Therapeutic Agent for Human Ovarian Cancer Stem/Progenitor Cells   
S40  Nonpharmacological Management of Osteoporosis 
S40-1  Nutrition in Bone: Optimizing Calcium & Vitamin D Intake for Prevention of Bone Loss   
S40-2  Exercise & Fall Prevention as Osteoporosis Management Strategies   
S40-3  Bad Habits & Bone: Alcohol, Tobacco & Caffeine   
S41  Therapeutic Interventions for Childhood Obesity: What Should We Expect? 
S41-1  Childhood Obesity & Premature Mortality: Targeting Co-Morbidities for Therapeutic Interventions   
S41-2  Present & Future of Pharmacological Interventions in Pediatric Obesity: Who, When & Which?   
S41-3  Surgical Interventions for Obesity in Adolescents & Young Adults   
S49  On the Quest for the Artificial Pancreas 
S49-1  Continuous Glucose Sensors: The Foundation for the Artificial Pancreas   
S49-2  Closed-Loop Systems or Artificial Pancreas: Limitations of Current Technologies   
S49-3  Artificial Pancreas: Emerging Technology?   
S50  Progestins & Cardiovascular Health in Women 
S50-1  Progesterone, the RAAS & Vascular Function in Women   
S50-2  Influence of Progestins on Cardiovascular (CV) Risk in Postmenopausal Women   
S50-3  Combined Oral Contraceptives & Cardiovascular (CV) Health in Premenopausal Women   
S51  Use of GH & GHRH in Abdominal Obesity: Progress & Pitfalls 
S51-1  Use of GHRH to Reduce Visceral Fat   
S51-2  Does GH Replacement Improve Metabolic Syndrome in GH Deficient Adults?   
S51-3  Investigative Use of GH in Abdominal Obesity   
S54  Adrenal Disorders in Children & Adolescents 
S54-1  Clinical Effects of Cushing's Syndrome in Children   
S54-3  Why Pediatric Adrenocortical Tumors Differ from Adult Tumors   
S58  Consequences of XX-cess in Men 
S58-1  Pathogenesis of Klinefelter's   
S58-2  Social and behavioral issues in Klinefelter syndrome   
S59  Controversies in Lipid Management 
S59-1  Sophisticated Lipid Tests: Are They Useful?   
S59-2  Should We Focus on Increasing HDL Levels?   
S59-3  Should We Lower Triglycerides?   
S61  Hunting for Genes & Wild Goose Chases 
S61-1  Whole Genome Sequencing for Endocrine Diseases: Promise & Pitfalls   
S61-2  Hunting for Fat in SNPs   
S61-3  Expanding the Phenotypes of Genetic Endocrine Diseases   
S68  Aggressive Pituitary Tumors 
S68-1  Recent Advances in Diagnosis & Treatment of Aggressive Pituitary Tumors & Pituitary Carcinomas   
S68-3  What Can Radiotherapy Offer?   
S69  Bone Quality: The Holy Frail 
S69-1  Imaging to Assess Bone Quality   
S69-2  Bone Remodeling Assessment & Interpretation   
S69-3  FRAX Update   
S70  Endocrine Therapies in Developmentally Disabled Children: Medical Challenges & Ethical Dilemmas 
S70-1  When Should We use Bisphosphonates in Children with Cerebral Palsy?   
S70-3  Ethical Issues in the Management of Puberty and Fertility in Children with Chronic Disabilities   
S71  Management of CAH: Beyond Childhood 
S71-1  Management of CAH in Adulthood   
S71-2  The 17-alpha & 11-beta Hydroxylase Deficiency Forms of Congenital Adrenal Hyperplasia   
S71-3  Management of CAH During Pregnancy: Optimizing Outcomes   
S77  Clinical Decision-Making In Thyroid Nodules & Cancer: Time for Molecular Profiling? 
S77-1  Molecular Diagnosis of Thyroid Nodules   
S77-2  Molecularly-Driven Initial Thyroid Cancer Management   
S77-3  Individualizing Therapy for Advanced Thyroid Cancer: Role of Molecular Testing   
S78  Recognition & Management of Atypical Forms of Diabetes 
S78-1  Monogenic Forms of Diabetes   
S78-2  Latent Autoimmune Diabetes in the Adult   
S78-3  Cystic Fibrosis Related Diabetes   
Y1  The Year in Bone   
Y2  The Year in Obesity   
Y4  The Year in Adrenal   
Back to Top
TRANSLATIONAL

L1-2  Presidential Plenary Lecture: Nuclear Receptors & Metabolism   
L1-3  Presidential Plenary Lecture: Nuclear Receptor Coactivators: Masters of Physiology & Disease   
L2-1  Endocrine Disrupting Contaminants & the Developing Reproductive System: The Wildlife to Human Connection   
L2-2  Sex Chromosome Evolution & Medicine   
L3-1  Gerald D. Aurbach Award Lecture: Obesity, Type 2 Diabetes & Cancer: The Insulin & IGF Connection   
L3-2  Clinical Investigator Award Lecture: From Base Change to Better Care in Neonatal Diabetes   
L4-1  Tissue-Specific Regulation of Thyroid Hormone Action   
L4-2  Bone Morphogenetic Proteins(BMPs)in the Musculoskeletal System   
L5-1  Edwin B. Astwood Award Lecture: Protein Folding Homeostasis & Metabolic Regulation   
L5-2  Glucocorticoids in Fetal Programming   
L6-1  Genetic Variation of the Androgen Receptor: From Gene Regulation to Prostate Cancer   
L6-2  Recent Findings from the WHI Hormone Therapy Trials: Do They Inform Clinical Decision Making?   
L7-1  Roy O. Greep Award Lecture: Epigenetics & Metabolism: The Circadian Link   
L8-1  MicroRNAs & their Targets in Pregnancy & Labor   
L8-2  Extra-Nuclear Steroid Receptor Functions   
S06  Nutrient Sensing Pathways in Longevity 
S06-1  Genetic Signature of Extreme Longevity   
S06-3  Endocrine Approaches to Retarding Aging   
S07  Ovarian Follicular Development in vitro: Implications for Fertility Preservation 
S07-1  Waking up Dormant Ovarian Follicles   
S07-2  Optimizing in-vitro maturation of oocytes from small antral follicles   
S07-3  In Vitro Maturation of Ovarian Follicles   
S15  Fat on Fire 
S15-1  Obesity, Inflammation & Macrophages   
S15-2  Anti-Inflammatories in Type 2 Diabetes: Clinical Trial   
S16  Molecular Mechanisms Involved in Male Fertility 
S16-1  Tales of Fertility in Men: Modeling meiosis via Post-Translational Modifications   
S16-2  Peritubular cells of the human testis: Emerging roles in health and disease   
S16-3  DNA Repair Deficiencies in Azoospermic Men   
S17  Who Wakes the Bugler? Mechanisms of Pubertal Onset 
S17-1  Genetic Variation & Timing of Puberty   
S17-2  Metabolic Control of Puberty Onset: New Players, New Mechanisms   
S24  Adipose Tissue: Adipocyte Fate 
S24-2  Resistin & Inflammation   
S24-3  Adiponectin & Adipose Tissue   
S25  Extra-Renal Actions of Aldosterone 
S25-1  Aldosterone as a Regulator of Inflammation   
S25-2  Aldosterone Regulation of Cardiac Rhythms   
S25-3  Aldosterone Regulation of Vascular Function   
S26  IGF System & Growth: Basic Mechanisms 
S26-1  IGF-1 Role in Skeletal Acquisition: Lessons from Mouse Models   
S26-3  IGF Deficiency & Growth Failure: Lessons from Mutational Analysis   
S27  Nutritional Regulation of GH Secretion 
S27-1  Effect of Body Mass on Stimulated GH Secretion in Children   
S27-2  Ghrelin: Physiological Significance & Therapeutic Potential   
S27-3  New Evidences Linking Orexigenic/Anorexigenic Signals & GH   
S28  Stop Right There! Emerging Targets to Block Sex Steroid Synthesis 
S28-3  Steroid Sulfatase Inhibitors for the Treatment of Hormone-Dependent Cancers: Where are We Now?   
S35  Advances in Adrenal Neoplasia 
S35-1  Aberrant Receptors in Primary Aldosteronism   
S35-2  Therapeutic Advances in Adrenocortical Cancer   
S35-3  Pheochromocytoma Susceptability Genes   
S36  Humanin & the Emerging Field of Mitochondrial Peptides 
S36-2  Humanin & Testes Biology   
S36-3  Metabolic Effects of Humanin in Diabetes: Related Models   
S37  Novel Influences on Hypothalamic Control of Reproductive Function in Females 
S37-1  The Metabolic Control of Reproductive Function   
S37-2  Adipokines in Female Reproductive Function   
S37-3  Genetic Susceptibility to Hypothalamic Amenorrhea   
S38  Putting on the Brakes/Breaks in Prostate Cancer 
S38-1  Androgen-Induced TOP2B Mediated Double Strand Breaks & Prostate Cancer   
S38-3  Small Molecular Inhibitors of Androgen Receptors   
S44  Basic Mechanisms of Mitochondrial Insulin Action 
S44-1  Mitochondrial Fatty Acid Oxidation Does Not Change Adiposity   
S44-2  Epigenetic Regulation of Metabolic Diseases   
S44-3  Mitochondrial Dysfunction in Obesity & Diabetes: Chicken or Egg?   
S45  Genetics & Epigenetics of Pituitary Tumors 
S45-1  Epidemiology & Genetics of Familial Isolated Pituitary Adenomas   
S45-2  The Role of AIP in Pituitary Tumorogenesis   
S45-3  Epigenetics of Pituitary Tumors   
S46  Mechanotransduction in Bone 
S46-1  Mechanical Signals as Anabolic Agents in Bone   
S46-2  Dendritic Processes & Cell Body Responses of Osteocytes to Fluid Flow   
S46-3  Mechanobiology: Loading Fracture & Risk in Humans   
S47  TSH in Thyroid Cancer Development & Progression: From Mouse to Man 
S47-1  Role of TSH in Mouse Models of Thyroid Cancer   
S47-2  Role of TSH in Risk of Cancer in Thyroid Nodules   
S47-3  TSH Suppression in Thyroid Cancer   
S48  Yin & Yang of the IGF System as a Treatment Strategy 
S48-1  Rational for Targeting IGF-1 Receptor in Cancer   
S48-2  Targeting Sarcomas Using Anti-IGF1 Receptor Therapies   
S48-3  The Vitronectin: IGF Complex as Treatment for Chronic Wounds   
S55  Novel Therapeutic Targets for Thyroid Disease 
S55-1  Thyroid Hormone Analogs: New Lipid-Lowering Drugs   
S55-2  K-Channels as Novel Targets in Thyroid Disease   
S55-3  Clinically-Relevant Targeting of the Membrane Thyroid Hormone Receptor   
S56  The Rewards of Sex: It's All Plastic 
S56-1  Estrogen Modulation of Hypothalmic Neuroplasticity   
S56-3  Sex Differences in Reward   
S57  Uterine Biology: Cell-Specific Actions of Steroid Hormones 
S57-1  Control of Endometrial Cell Fate by Steroid Hormones & FOXO Transcription Factors   
S57-2  Steroidal Regulation of Embryo Implantation: Insights from New Mouse Models   
S57-3  Progesterone Resistance in Endometriosis   
S66  How Does GH Signal? 
S66-2  Novel Aspects of GH Receptor Signaling   
S66-3  GH Receptor Activation   
S67  Signaling in Mammary Gland Proliferation & Neoplasia 
S67-1  Plasma Membrane Calcium ATPase & Mammary Gland Apoptosis/Neoplasia   
S67-2  Novel Anti-JAK Therapies Against Breast Cancer   
S67-3  Role of Musashi1 Signaling in Breast Cancer   
S74  Estrogen Receptors in Cancer 
S74-1  Receptor Modifications & Breast Cancer   
S74-2  NF-KB & Estrogen Receptor Cross-Talk in Breast Cancer   
S75  Organizational Effects of Estrogen across the Lifespan 
S75-1  Estrogen Regulation of Neuroendocrine Circuits during Postnatal Development   
S75-2  Hypothalamic Changes with Aging/Menopause   
S75-3  Neuroendocrine Effects of Estrogens during Embryonic Development   
S76  TGF-beta Receptor Superfamily I, II & III 
S76-1  TGFß; Receptor 1 & Colon Cancer   
S76-3  TGFß; Receptor III & Cancer Predisposition   
Back to Top
BASIC

SBS1  Special Basic Science Session: Nuclear Receptors: Past, Present & Future 
SBS1-2  Historical Perspectives on Nuclear Receptor Research   
Y3  The Year in Orphan Nuclear Receptors   
Y5  The Year in Endocrine Genetics for Basic Scientists   
Back to Top